Search research articles

Search research articles

Related Experiment Videos

Vaccination with messenger RNA.

Steve Pascolo¹

¹CureVac GmbH, Tubingen, Germany.

Methods in Molecular Medicine

|September 22, 2006

Summary

This summary is machine-generated.

Messenger RNA (mRNA)-based vaccines offer safety advantages over DNA vaccines, including no persistence or genome integration. This chapter details mRNA production and the preparation of two leading mRNA vaccine types for human clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8<sup>+</sup> T cells.

Nature biomedical engineering·2026

Same author

NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasis.

Cell death & disease·2026

Same author

Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation.

Molecular therapy. Nucleic acids·2025

Same author

Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models.

Science translational medicine·2025

Same author

Development of Thermostable and Immunogenic Block Copolymer Nanoparticles (BNPs) for mRNA Delivery.

Biomacromolecules·2025

Same author

LL37 complexed to double-stranded RNA induces RIG-I-like receptor signalling and Gasdermin E activation facilitating IL-36γ release from keratinocytes.

Cell death & disease·2025

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Area of Science:

Biotechnology
Vaccinology
Molecular Biology

Background:

Messenger RNA (mRNA)-based vaccines are emerging as a safe alternative to DNA-based vaccines.
mRNA vaccines offer advantages such as lack of genomic integration and autoantibody induction.
In vitro transcription allows for large-scale, high-purity mRNA production, ensuring reproducibility.

Purpose of the Study:

To describe the production of mRNA for vaccine development.
To detail the preparation of two distinct mRNA-based vaccine types evaluated in human clinical trials.

Main Methods:

mRNA production via in vitro transcription.
Vaccine preparation methods including direct injection of naked mRNA, liposomal encapsulation, Gene Gun delivery, and in vitro transfection of cells.

Related Experiment Videos

Focus on two clinical trial technologies: in vitro mRNA-transfected dendritic cells and direct injection of globin-stabilized mRNA.

Main Results:

The described methods facilitate Good Manufacturing Practices (GMP) and ensure batch-to-batch consistency.
Two mRNA vaccine strategies are currently under evaluation in human clinical trials.

Conclusions:

mRNA vaccine technology is a promising platform with inherent safety features.
Standardized production and diverse delivery methods support the advancement of mRNA vaccines into clinical practice.